Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Large Value · Heartland Group

Heartland Value Plus Fund Investor Class (HRVIX)

Ticker HRVIX · Since 1993-10-26 · · Holdings as of Jun 30, 2026

Expense ratio
1.22%$122/yr per $10k
5-yr return
+4.0%annualized
1-yr return
+1.1%as of Dec 2025
Net assets
$330.8Mall share classes
Holdings
55

Bottom line

Is HRVIX a good fund? The bottom line

HRVIX is the Investor Class share class of Heartland Value Plus Fund, an actively managed large value mutual fund from Heartland Group.

Annual fees run 1.22% — about $122 a year on every $10,000 invested, more expensive than 79% of large value funds we track.

It returned +1.1% over one year, +4.0% a year over five years, +7.6% a year over ten (as of Dec 31, 2025, per its prospectus).

With $331 million in net assets and 55 holdings, its largest position is Materion Corp (3.4%) and the top 10 make up 29.5% of the portfolio.

What stands out

  • No front-end sales load

What to watch

  • Expensive for its category (1.22%)
  • 5-year return in the bottom quarter of its category
  • 12b-1 marketing fee of 0.25% a year

Updated Nov 19, 2026

What HRVIX invests in

The Value Plus Fund seeks long-term capital appreciation and modest current income.

The Value Plus Fund invests primarily in a limited number (generally 40 to 70) of small-capitalization common stocks selected on a value basis. A majority of its assets are generally invested in dividend-paying common stocks. The Fund invests a majority of its assets in companies with market capitalizations consistent with the capitalization range of the Russell 2000 Value Index. As of April 30, 2025, the market capitalization range of the Russell 2000 Value Index was $119.4 million to $7.4 billion. The median market capitalization of the Fund is expected to fluctuate over time depending on Heartland Advisors perceptions of relative valuations, future prospects, and market conditions. The Fund utilizes Heartland Advisors disciplined and time-tested 10 Principles of Value Investing TM framework to identify securities with the potential for appreciation and a potential margin of safety…

From the fund's prospectus (filed Apr 29, 2026).

HRVIX performance

Fund calendar-year total returns, 2016–2025 2016: +26.8%; 2017: +9.8%; 2018: −13.1%; 2019: +26.0%; 2020: +12.6%; 2021: +24.9%; 2022: −5.0%; 2023: +1.8%; 2024: −0.3%; 2025: +1.1% +27% 2016 +10% 2017 −13% 2018 +26% 2019 +13% 2020 +25% 2021 −5% 2022 +2% 2023 −0% 2024 +1% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
HRVIX+1.1%+4.0%+7.6%
Large Value median+13.6%+11.3%+10.2%

Source: Fund prospectus, as of Dec 31, 2025

Full HRVIX performance history →

What HRVIX costs

On a $10,000 investment, HRVIX's 1.22% expense ratio costs about $122 a year. The prospectus estimates $1,476 in total costs over 10 years (assuming 5% annual returns). The median large value fund charges 0.81%.

See the full HRVIX fee table →

HRVIX top 10 holdings

#Holding% of fund
1Materion Corp3.37%
2Royalty Pharma Plc3.22%
3Lamar Advertising Co3.07%
4Littelfuse Inc3.03%
5Fnb Corp/pa3.03%
6Associated Banc-corp3.02%
7Renasant Corp2.89%
8Seacoast Banking Corp Of Florida2.76%
9Envista Holdings Corp2.59%
10Silicon Motion Technology Corp2.52%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 29.5% of the fund. See all top 25 holdings and asset mix →

Alternatives to HRVIX

More funds like HRVIX →

HRVIX FAQ

What is the expense ratio of HRVIX?
HRVIX's expense ratio is 1.22%, which works out to about $122 a year for every $10,000 invested. The prospectus estimates total costs of $1,476 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is HRVIX a good investment?
It depends on your goals, but the data points to: no front-end sales load; expensive for its category (1.22%); 5-year return in the bottom quarter of its category; 12b-1 marketing fee of 0.25% a year. This is general information, not personalized advice.
What does HRVIX hold?
HRVIX's largest holdings are Materion Corp (3.4%), Royalty Pharma Plc (3.2%), Lamar Advertising Co (3.1%), Littelfuse Inc (3.0%), Fnb Corp/pa (3.0%). It holds 55 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is HRVIX's 5-year return?
HRVIX returned +4.0% a year over the five years ending Dec 31, 2025, and +7.6% a year over ten years. Past performance does not guarantee future results.
Does HRVIX have a sales load?
No. HRVIX has no front-end sales charge.
Who manages HRVIX?
HRVIX is offered by Heartland Group through Heartland Group Inc.